Subscription AgreementSubscription Agreement • July 30th, 2008 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 30th, 2008 Company Industry JurisdictionThis subscription agreement (this “Agreement”) is dated July 28, 2008, by and between the investor identified on the signature page hereto (the “Investor”) and Novavax, Inc., a Delaware corporation (the “Company”), whereby the parties agree as set forth herein. Certain terms are defined in Section 7 of this Agreement:
Investor Rights AgreementInvestor Rights Agreement • July 30th, 2008 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledJuly 30th, 2008 Company Industry JurisdictionTHIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of July 29, 2008, by and among Novavax, Inc., a Delaware corporation (the “Corporation”), Abingworth Bioventures V LP, and Abingworth Bioequities Master Fund Limited (each an “Investor” and, collectively, the “Investors” ).